Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XBI vs FBTAX overlap: 21% of top holdings shared

Bottom line

How much do XBI and FBTAX overlap?

21% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 8.7% of XBI's assets and 18.0% of FBTAX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

XBIFBTAX
Weight overlap (top 25)21%
Shared holdings7
Weight in shared holdings8.7%18.0%
Total positions161129
Expense ratio0.35%0.94%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings XBI and FBTAX have in common

Holding% of XBI% of FBTAXOverlap
Moderna Inc1.41%1.60%1.41%
Oruka Therapeutics Inc1.38%3.24%1.38%
Revolution Medicines Inc1.20%3.00%1.20%
Vaxcyte Inc1.19%1.97%1.19%
Dianthus Therapeutics Inc1.18%3.55%1.18%
Natera Inc1.16%1.43%1.16%
Cogent Biosciences Inc1.14%3.25%1.14%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XBI

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Twist Bioscience Corp — 1.41%
  4. Kymera Therapeutics Inc — 1.36%
  5. Viking Therapeutics Inc — 1.30%
  6. Praxis Precision Medicines Inc — 1.29%
  7. Erasca Inc — 1.27%
  8. Rhythm Pharmaceuticals Inc — 1.20%
  9. CG oncology Inc — 1.20%
  10. SELLAS Life Sciences Group Inc — 1.19%
  11. Cytokinetics Inc — 1.18%
  12. Scholar Rock Holding Corp — 1.16%
  13. Roivant Sciences Ltd — 1.16%
  14. Mirum Pharmaceuticals Inc — 1.16%
  15. Ultragenyx Pharmaceutical Inc — 1.14%

Only in FBTAX

  1. Abbvie Inc — 14.71%
  2. Gilead Sciences Inc — 5.70%
  3. Spyre Therapeutics Inc — 3.83%
  4. Alnylam Pharmaceuticals Inc — 3.62%
  5. Insmed Inc — 3.05%
  6. Argenx Se — 3.00%
  7. Ascendis Pharma A/s — 2.99%
  8. Biogen Inc — 2.71%
  9. Mbx Biosciences Inc — 2.45%
  10. Amgen Inc — 2.37%
  11. Amylyx Pharmaceuticals Inc — 2.25%
  12. Fidelity Revere Street Trust — 1.96%
  13. Relay Therapeutics Inc — 1.58%
  14. Viridian Therapeutics Inc — 1.53%
  15. Kiniksa Pharmaceuticals International Plc — 1.41%

Asset mix

Asset typeXBIFBTAX
Stocks99.9%98.2%
Cash & short-term funds5.9%2.4%
Preferred stock—1.5%
Bonds—0.1%
Equity derivatives0.1%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryXBIFBTAX
US100.8%87.8%
NL1.0%4.3%
DK—3.0%
KY—1.8%
GB—1.8%
CA0.2%1.4%
IE1.2%—
BM1.2%1.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do XBI and FBTAX overlap?
About 21% by weight. 7 securities appear in both funds' top 25 holdings; they make up 8.7% of XBI's assets and 18.0% of FBTAX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do XBI and FBTAX have in common?
The largest shared holdings are Moderna Inc, Oruka Therapeutics Inc, Revolution Medicines Inc, Vaxcyte Inc, Dianthus Therapeutics Inc.
Should I own both XBI and FBTAX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, XBI or FBTAX?
XBI is broader, with 161 positions versus 129 for FBTAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.